MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.
MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.
Not yet recruiting · NCT05888857 · Registry updated 2025-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors. | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Tertiary Lymphoid Structures | Not yet recruiting | Phase 2 | 2025-08-13 | NCT05888857 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Institut Bergonié | 27 |
| National Cancer Institute, France | 61 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institut Bergonie | Bordeaux | France | 53 |